This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Glucagon-like peptide-1 class drugs show clear protective effects in Parkinson's and Alzheimer's disease clinical trials: A revolution in the making?
Neuropharmacology, 253, 109952
Citation
Hölscher, Christian. (2024). Glucagon-like peptide-1 class drugs show clear protective effects in Parkinson's and Alzheimer's disease clinical trials: A revolution in the making?. Neuropharmacology, 253, 109952. https://doi.org/10.1016/j.neuropharm.2024.109952